Imperial College London

ProfessorRobinShattock

Faculty of MedicineDepartment of Infectious Disease

Chair in Mucosal Infection and Immunity
 
 
 
//

Contact

 

+44 (0)20 7594 5206r.shattock

 
 
//

Location

 

453Wright Fleming WingSt Mary's Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Haidari:2016,
author = {Haidari, G and Cope, A and Miller, A and Ridgers, H and Venables, S and Yan, C and Reijonen, K and Hannaman, D and Spentzou, A and Hayes, P and Bouliotis, G and Joseph, S and Combadiere, B and McCormack, S and Shattock, RJ},
pages = {391--391},
publisher = {MARY ANN LIEBERT, INC},
title = {CUTHIVAC 001: Results from a Phase I Clinical Trial of a Prophylactic Clade B HIV-1 DNA Vaccine Comparing Multiple Routes of Administration},
url = {http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000386774600731&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202},
year = {2016}
}

RIS format (EndNote, RefMan)

TY  - CPAPER
AU - Haidari,G
AU - Cope,A
AU - Miller,A
AU - Ridgers,H
AU - Venables,S
AU - Yan,C
AU - Reijonen,K
AU - Hannaman,D
AU - Spentzou,A
AU - Hayes,P
AU - Bouliotis,G
AU - Joseph,S
AU - Combadiere,B
AU - McCormack,S
AU - Shattock,RJ
EP - 391
PB - MARY ANN LIEBERT, INC
PY - 2016///
SN - 0889-2229
SP - 391
TI - CUTHIVAC 001: Results from a Phase I Clinical Trial of a Prophylactic Clade B HIV-1 DNA Vaccine Comparing Multiple Routes of Administration
UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000386774600731&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
ER -